Chemed Corporation
CHE
$534.91
$0.030.01%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.31% | 2.07% | 4.06% | 6.45% | 7.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.31% | 2.07% | 4.06% | 6.45% | 7.55% |
| Cost of Revenue | 4.14% | 5.90% | 8.23% | 11.06% | 11.44% |
| Gross Profit | 1.67% | -5.09% | -3.65% | -1.85% | 0.62% |
| SG&A Expenses | 6.30% | 2.21% | -1.08% | 0.18% | -0.17% |
| Depreciation & Amortization | 4.10% | 3.86% | 2.84% | 2.53% | 2.19% |
| Other Operating Expenses | 86.54% | -43.90% | -- | 96.45% | 96.73% |
| Total Operating Expenses | 4.56% | 5.11% | 6.17% | 8.63% | 8.80% |
| Operating Income | -3.93% | -14.30% | -7.63% | -5.30% | 0.83% |
| Income Before Tax | -4.84% | -15.03% | -10.94% | -6.20% | 0.20% |
| Income Tax Expenses | -3.52% | -12.51% | -7.11% | -1.67% | 13.15% |
| Earnings from Continuing Operations | -5.29% | -15.86% | -12.17% | -7.60% | -3.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.29% | -15.86% | -12.17% | -7.60% | -3.51% |
| EBIT | -3.93% | -14.30% | -7.63% | -5.30% | 0.83% |
| EBITDA | -2.78% | -11.88% | -6.18% | -4.17% | 1.08% |
| EPS Basic | 1.56% | -11.26% | -8.29% | -4.77% | -1.52% |
| Normalized Basic EPS | 3.47% | -9.02% | -6.81% | -5.04% | 0.43% |
| EPS Diluted | 2.32% | -10.65% | -7.77% | -4.42% | -1.34% |
| Normalized Diluted EPS | 4.28% | -8.36% | -6.25% | -4.66% | 0.61% |
| Average Basic Shares Outstanding | -6.52% | -4.94% | -4.15% | -3.12% | -2.15% |
| Average Diluted Shares Outstanding | -7.24% | -5.59% | -4.71% | -3.54% | -2.35% |
| Dividend Per Share | 20.00% | 21.05% | 22.22% | 23.53% | 25.00% |
| Payout Ratio | 0.19% | 0.36% | 0.33% | 0.30% | 0.26% |